Stronger Sell Today AIMT ranks #3960 as SELL CANDIDATE. Weaker Sell
Today AIMT ranks #3960 as SELL CANDIDATE.

AIMT stock Aimmune Therapeutics

AIMT stock
Aimmune Therapeutics

March 21, 2019
Change 4.35%
Chart period: 2018-12-24 - 2019-03-21
VOLUME
Sell
TREND
Sell

MV LONG
Sell

MV SHORT
Sell

PIVOT
Buy

MACD
Sell

Will AIMT stock price go up or down on Mon, 25 Mar 2019?

Aimmune Therapeutics Forecast and Stock Analysis

Technical AIMT stock analysis for March 21, 2019.

Sell candidate since 2019-03-14 Loss -5.44%
Shorts n/a
Cash n/a
Loans n/a
Beta -0.18
ROA -77.13

Aimmune Therapeutics gained 4.35% in the last trading day, rising from $21.15 to $22.07 The price has fallen in 6 of the last 10 days and is down by -5.72% for this period. Volume fell in the last day by -8 146 shares, and in total, 435 255 shares bought and sold for approximately $9.61 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Close price at the end of the last trading day (Thursday, 21st Mar 2019) of the AIMT stock was $22.07. This is 4.35% more than the trading day before Wednesday, 20th Mar 2019.

During day the stock fluctuated 6.12% from a day low at $20.94 to a day high of $22.22.

30 day high of the AIMT stock price was $25.81 and low was $20.94.
90 day high was $26.68 and low was $20.94.
52 week high for the Aimmune Therapeutics - $36.12 and low - $20.94.

Trend

Aimmune Therapeutics lies in the middle of a wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.19% during the next 3 months and, with 90% probability hold a price between $20.44 and $24.86 at the end of this period.

Click here for today's Top 5 Trending Companies

Signals

A buy signal was issued from a pivot bottom point on Wednesday March 20, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Aimmune Therapeutics holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $22.53 and $23.70. A break-up above any of these levels will issue buy signals.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 31 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Aimmune Therapeutics finds support from accumulated volume at $21.94.

Support: $21.94 Price: $22.07 Resistance: $23.73

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.28 between high and low, or 6.12%. For the last week, the stock has had a daily average volatility of 4.29%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High

Evaluation: Sell Candidate

Aimmune Therapeutics holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Stronger Sell Today AIMT ranks #3960 as SELL CANDIDATE. Weaker Sell
Today AIMT ranks #3960 as SELL CANDIDATE.